Dudediligence.

Halozyme Therapeutics, Inc

HALONASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$53.4M

12 notices · 627,213 sh

Oct 2025 to Oct 2026

Reported ·

$25.5M

62 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

58 of 62 reported sales carry the 10b5-1 box. Together they are 0.32% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-16: MATTHEW POSARD, Form 1442026-08-17: Helen Torley, Form 1442026-08-11: CORTNEY A CAUDILL, Form 1442026-08-10: BERNADETTE CONNAUGHTON, Form 1442026-06-29: MAHESH KRISHNAN, Form 1442026-05-15: NICOLE LABROSSE, Form 1442026-05-11: Helen Torley, Form 1442026-05-01: BERNADETTE CONNAUGHTON, Form 1442026-03-10: CORTNEY A CAUDILL, Form 1442026-03-09: CORTNEY A CAUDILL, Form 1442026-02-03: Helen Torley, Form 1442026-01-05: BERNADETTE CONNAUGHTON, Form 1442025-11-01: Caudill Cortney, sold2025-11-10: Connaughton Bernadette, sold2025-11-10: Torley Helen, sold2025-12-01: Torley Helen, sold2025-12-01: Connaughton Bernadette, sold2026-01-05: Connaughton Bernadette, sold2026-02-03: Torley Helen, sold2026-03-02: Torley Helen, sold2026-03-09: Caudill Cortney, sold2026-04-01: Torley Helen, sold2026-04-06: Torley Helen, sold2026-05-01: Connaughton Bernadette, sold2026-05-11: Torley Helen, sold2026-06-01: Connaughton Bernadette, sold2026-06-01: Torley Helen, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-16MATTHEW POSARD, Director$3,636,513
34,226 shplan 2026-06-15Form 4s on file end Jun 23144 ↗
2026-08-17Helen Torley, PRESIDENT AND CEO$23.7M
240,000 shplan 2025-12-03Form 4s on file end Jun 23144 ↗
2026-08-11CORTNEY A CAUDILL, SVP, CHIEF OPERATING OFFICER$4,302,349
41,702 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-10BERNADETTE CONNAUGHTON, Director$167,673
1,626 shplan 2025-05-29Form 4s on file end Jun 23144 ↗
2026-06-29MAHESH KRISHNAN, Director$547,508
7,304 shplan 2026-03-19144 ↗
Form 4, 2026-06-30: sold 7,304 at $75.00 Form 4 ↗
2026-05-15NICOLE LABROSSE, SVP, CHIEF FINANCIAL OFFICER$986,592
14,700 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-11Helen Torley, PRESIDENT AND CEO$6,535,303
101,923 shplan 2025-03-21144 ↗
Form 4, 2026-05-13: sold 50,000 at $68.68 Form 4 ↗
2026-05-01BERNADETTE CONNAUGHTON, Director$310,343
4,875 shplan 2025-05-29144 ↗
Form 4, 2026-05-05: sold 1,625 at $63.48 Form 4 ↗
2026-03-10CORTNEY A CAUDILL, SVP, CHIEF OPERATING OFFICER$599,088
8,857 shno plan dateno Form 4 on file144 ↗
2026-03-09CORTNEY A CAUDILL, SVP, CHIEF OPERATING OFFICER$1,356,062
20,000 shno plan date144 ↗
Form 4, 2026-03-10: sold 28,857 at $67.75 Form 4 ↗
2026-02-03Helen Torley, PRESIDENT AND CEO$11.2M
150,000 shplan 2025-03-21144 ↗
Form 4, 2026-02-05: sold 50,000 at $77.07 Form 4 ↗
2026-01-05BERNADETTE CONNAUGHTON, Director$140,620
2,000 shplan 2025-05-29144 ↗
Form 4, 2026-01-06: sold 2,000 at $70.25 Form 4 ↗